000 | 01236 a2200337 4500 | ||
---|---|---|---|
005 | 20250512004417.0 | ||
264 | 0 | _c19890825 | |
008 | 198908s 0 0 eng d | ||
022 | _a0770-3198 | ||
024 | 7 |
_a10.1007/BF02214106 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDvornik, D | |
245 | 0 | 0 |
_aTheoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins. _h[electronic resource] |
260 |
_bClinical rheumatology _cMar 1989 |
||
300 |
_a16-24 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xbiosynthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 |
_aDinoprostone _xbiosynthesis |
650 | 0 | 4 | _aEtodolac |
650 | 0 | 4 |
_aGastric Mucosa _xdrug effects |
650 | 0 | 4 |
_aGastritis _xchemically induced |
650 | 0 | 4 |
_aIndoleacetic Acids _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
700 | 1 | _aLee, D K | |
773 | 0 |
_tClinical rheumatology _gvol. 8 Suppl 1 _gp. 16-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02214106 _zAvailable from publisher's website |
999 |
_c2531947 _d2531947 |